143 related articles for article (PubMed ID: 29355752)
1. Binding of vanadium to human serum transferrin - voltammetric and spectrometric studies.
Azevedo CG; Correia I; Dos Santos MMC; Santos MFA; Santos-Silva T; Doutch J; Fernandes L; Santos HM; Capelo JL; Pessoa JC
J Inorg Biochem; 2018 Mar; 180():211-221. PubMed ID: 29355752
[TBL] [Abstract][Full Text] [Related]
2. Interaction of vanadium(IV) with human serum apo-transferrin.
Mehtab S; Gonçalves G; Roy S; Tomaz AI; Santos-Silva T; Santos MF; Romão MJ; Jakusch T; Kiss T; Pessoa JC
J Inorg Biochem; 2013 Apr; 121():187-95. PubMed ID: 23411030
[TBL] [Abstract][Full Text] [Related]
3. Interaction of [V
Correia I; Chorna I; Cavaco I; Roy S; Kuznetsov ML; Ribeiro N; Justino G; Marques F; Santos-Silva T; Santos MFA; Santos HM; Capelo JL; Doutch J; Pessoa JC
Chem Asian J; 2017 Aug; 12(16):2062-2084. PubMed ID: 28651041
[TBL] [Abstract][Full Text] [Related]
4. V
Sanna D; Ugone V; Sciortino G; Buglyó P; Bihari Z; Parajdi-Losonczi PL; Garribba E
Dalton Trans; 2018 Feb; 47(7):2164-2182. PubMed ID: 29327005
[TBL] [Abstract][Full Text] [Related]
5. A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding.
Gonçalves G; Tomaz I; Correia I; Veiros LF; Castro MM; Avecilla F; Palacio L; Maestro M; Kiss T; Jakusch T; Garcia MH; Pessoa JC
Dalton Trans; 2013 Sep; 42(33):11841-61. PubMed ID: 23677414
[TBL] [Abstract][Full Text] [Related]
6. Differential binding of apo and holo human transferrin to meningococci and co-localisation of the transferrin-binding proteins (TbpA and TbpB).
Powell NB; Bishop K; Palmer HM; Ala'Aldeen DA; Gorringe AR; Borriello SP
J Med Microbiol; 1998 Mar; 47(3):257-64. PubMed ID: 9511831
[TBL] [Abstract][Full Text] [Related]
7. Transferrin serves as a mediator to deliver organometallic ruthenium(II) anticancer complexes into cells.
Guo W; Zheng W; Luo Q; Li X; Zhao Y; Xiong S; Wang F
Inorg Chem; 2013 May; 52(9):5328-38. PubMed ID: 23586415
[TBL] [Abstract][Full Text] [Related]
8. Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS.
Nagaoka MH; Yamazaki T; Maitani T
Biochem Biophys Res Commun; 2002 Sep; 296(5):1207-14. PubMed ID: 12207902
[TBL] [Abstract][Full Text] [Related]
9. A molecular docking study of the interactions between human transferrin and seven metallocene dichlorides.
Güette-Fernández JR; Meléndez E; Maldonado-Rojas W; Ortega-Zúñiga C; Olivero-Verbel J; Parés-Matos EI
J Mol Graph Model; 2017 Aug; 75():250-265. PubMed ID: 28609757
[TBL] [Abstract][Full Text] [Related]
10. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies.
Sanna D; Ugone V; Pisano L; Serra M; Micera G; Garribba E
J Inorg Biochem; 2015 Dec; 153():167-177. PubMed ID: 26281973
[TBL] [Abstract][Full Text] [Related]
11. Vanadium(V/IV)-Transferrin Binding Disrupts the Transferrin Cycle and Reduces Vanadium Uptake and Antiproliferative Activity in Human Lung Cancer Cells.
Levina A; Lay PA
Inorg Chem; 2020 Nov; 59(22):16143-16153. PubMed ID: 32578416
[TBL] [Abstract][Full Text] [Related]
12. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin.
Bordbar AK; Creagh AL; Mohammadi F; Haynes CA; Orvig C
J Inorg Biochem; 2009 Apr; 103(4):643-7. PubMed ID: 19056126
[TBL] [Abstract][Full Text] [Related]
13. Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS.
Nagaoka MH; Akiyama H; Maitani T
Analyst; 2004 Jan; 129(1):51-4. PubMed ID: 14737583
[TBL] [Abstract][Full Text] [Related]
14. X-ray Characterization of Conformational Changes of Human Apo- and Holo-Transferrin.
Campos-Escamilla C; Siliqi D; Gonzalez-Ramirez LA; Lopez-Sanchez C; Gavira JA; Moreno A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948188
[TBL] [Abstract][Full Text] [Related]
15. Competition between Al
Ott DB; Hartwig A; Stillman MJ
Metallomics; 2019 May; 11(5):968-981. PubMed ID: 30916671
[TBL] [Abstract][Full Text] [Related]
16. The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding.
Wally J; Halbrooks PJ; Vonrhein C; Rould MA; Everse SJ; Mason AB; Buchanan SK
J Biol Chem; 2006 Aug; 281(34):24934-44. PubMed ID: 16793765
[TBL] [Abstract][Full Text] [Related]
17. Expression of functional human transferrin in stably transfected Drosophila S2 cells.
Lim HJ; Kim YK; Hwang DS; Cha HJ
Biotechnol Prog; 2004; 20(4):1192-7. PubMed ID: 15296447
[TBL] [Abstract][Full Text] [Related]
18. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Sun H; McArdle HJ; Gambling L; Sadler PJ
Biochemistry; 2000 Aug; 39(33):10023-33. PubMed ID: 10955990
[TBL] [Abstract][Full Text] [Related]
19. Interaction of insulin-enhancing vanadium compounds with human serum holo-transferrin.
Sanna D; Micera G; Garribba E
Inorg Chem; 2013 Oct; 52(20):11975-85. PubMed ID: 24090437
[TBL] [Abstract][Full Text] [Related]
20. Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe.
Yang N; Zhang H; Wang M; Hao Q; Sun H
Sci Rep; 2012; 2():999. PubMed ID: 23256035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
